On June 2, 2023 UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, reported that it will present at the following investor conferences in June (Press release, UroGen Pharma, JUN 2, 2023, View Source [SID1234632399]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jefferies 2023 Healthcare Conference — June 7-9, 2023

Fireside Chat Date: Friday, June 9th from 12:45-1:10pm ET
Webcast Link: View Source

Goldman Sachs 44th Annual Global Healthcare Conference — June 12-15, 2023

Fireside Chat: Wednesday, June 14th from 4:00-4:35pm ET
Webcast Link: View Source
Webcasts for both the Jefferies and Goldman Sachs fireside chats will be available via the Investors section of UroGen’s website, www.urogen.com. A replay of each webcast will be available on the Company’s website for approximately 90 days.